Get the Stockscreener App
15.78
2.27%
0.35
Pre-market:
15.61
-0.17
-1.08%
Phreesia Inc stock is traded at $15.78, with a volume of 4.12M.
It is up +2.27% in the last 24 hours and down -30.24% over the past month.
Phreesia Inc is a provider of comprehensive software solutions that improve the operational and financial performance of healthcare organizations by activating patients in their care to optimize patient health outcomes. Through its SaaS-based technology platform, it offers healthcare services clients a robust suite of integrated solutions that manage patient access, registration, payments, and clinical support. The Phreesia Platform encompasses a comprehensive range of technologies and services, including, initial patient contact, registration, automated answering services, appointment scheduling, payments, and post-appointment patient surveys.
See More
Previous Close:
$15.43
Open:
$15.69
24h Volume:
4.12M
Relative Volume:
4.21
Market Cap:
$950.50M
Revenue:
$434.53M
Net Income/Loss:
$-42.72M
P/E Ratio:
-21.32
EPS:
-0.74
Net Cash Flow:
$21.88M
1W Performance:
-22.57%
1M Performance:
-30.24%
6M Performance:
-43.68%
1Y Performance:
-34.63%
1-Day Range:
$15.46
$16.58
1-Week Range:
$15.41
$21.24
52-Week Range:
$15.41
$32.76
Phreesia Inc Stock (PHR) Company Profile
Name
Phreesia Inc
Sector
Industry
Phone
888-654-7473
Address
1521 CONCORD PIKE, WILMINGTON
Compare PHR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PHR
Phreesia Inc
|
15.78 | 929.42M | 434.53M | -42.72M | 21.88M | -0.74 |
|
VEEV
Veeva Systems Inc
|
229.16 | 38.14B | 3.08B | 860.33M | 1.35B | 5.1463 |
|
TEM
Tempus Ai Inc
|
75.07 | 13.50B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
DOCS
Doximity Inc
|
45.04 | 8.50B | 550.17M | 201.35M | 232.07M | 1.00 |
|
HQY
Healthequity Inc
|
95.73 | 7.97B | 1.15B | 96.70M | -161.99M | 1.09 |
|
BTSG
Brightspring Health Services Inc
|
35.20 | 6.39B | 11.99B | 24.18M | 234.31M | 0.2956 |
Phreesia Inc Stock (PHR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-09-25 | Initiated | Barclays | Overweight |
| Nov-13-25 | Initiated | BMO Capital Markets | Outperform |
| Sep-05-25 | Resumed | DA Davidson | Buy |
| Aug-27-25 | Initiated | Mizuho | Outperform |
| Jan-08-25 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Feb-26-24 | Initiated | Truist | Buy |
| Jan-17-24 | Upgrade | DA Davidson | Neutral → Buy |
| Jan-03-24 | Initiated | Barclays | Overweight |
| Apr-12-23 | Initiated | Stephens | Overweight |
| Jan-04-23 | Reiterated | Needham | Buy |
| Dec-13-22 | Upgrade | Citigroup | Neutral → Buy |
| Dec-09-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Oct-13-22 | Initiated | DA Davidson | Neutral |
| Sep-16-22 | Initiated | KeyBanc Capital Markets | Overweight |
| Apr-14-22 | Initiated | Guggenheim | Buy |
| Jan-06-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Dec-02-21 | Initiated | Jefferies | Buy |
| Sep-02-21 | Reiterated | Needham | Buy |
| Aug-27-21 | Initiated | Canaccord Genuity | Buy |
| Jul-13-21 | Initiated | JMP Securities | Mkt Outperform |
| Jun-08-21 | Initiated | Berenberg | Buy |
| Apr-29-21 | Resumed | JP Morgan | Overweight |
| Apr-01-21 | Initiated | Robert W. Baird | Outperform |
| Nov-11-20 | Initiated | Stephens | Overweight |
| Oct-27-20 | Initiated | Needham | Buy |
| Sep-22-20 | Initiated | DA Davidson | Buy |
| Jul-14-20 | Initiated | Citigroup | Neutral |
| May-15-20 | Initiated | Guggenheim | Buy |
| Apr-21-20 | Initiated | RBC Capital Mkts | Sector Perform |
| Apr-13-20 | Initiated | SVB Leerink | Outperform |
| Jan-31-20 | Initiated | KeyBanc Capital Markets | Overweight |
| Jan-09-20 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-20-19 | Initiated | Raymond James | Outperform |
| Oct-11-19 | Initiated | Robert W. Baird | Outperform |
| Aug-13-19 | Initiated | JP Morgan | Overweight |
| Aug-12-19 | Initiated | Piper Jaffray | Overweight |
| Aug-12-19 | Initiated | Wells Fargo | Outperform |
| Aug-12-19 | Initiated | William Blair | Outperform |
| Jul-23-19 | Initiated | Chardan Capital Markets | Buy |
View All
Phreesia Inc Stock (PHR) Latest News
PHR Analyst Ratings Update: Mizuho Lowers Price Target | PHR Sto - GuruFocus
Phreesia (PHR) Loses 32.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Yahoo Finance Singapore
MercyOne partners with Phreesia to automate social needs screenings - Business Record
PHR Stock: Baird Lowers Price Target, Maintains Outperform Ratin - GuruFocus
Phreesia stock hits 52-week low at $18.17 amid market challenges - Investing.com Canada
Why Phreesia Stock Plummeted by 23% Today - Yahoo Finance
Mizuho lowers Phreesia stock price target to $28 on pharma spending concerns - Investing.com Nigeria
Phreesia, Inc. SEC 10-Q Report - TradingView
PHR: Citigroup Lowers Price Target While Maintaining Buy Rating - GuruFocus
Is Phreesia a Hidden Opportunity After Recent Digital Patient Intake Partnerships? - Yahoo Finance
Needham Reiterates Buy Rating for Phreesia (PHR) with $35 Price Target | PHR Stock News - GuruFocus
Canaccord Genuity Lowers Price Target for Phreesia (PHR) | PHR S - GuruFocus
Canaccord Genuity lowers Phreesia stock price target to $33 on revenue outlook - Investing.com Nigeria
DA Davidson reiterates Buy rating on Phreesia stock, maintains $35 price target - Investing.com Nigeria
Phreesia (PHR) Gains Momentum with New "Overweight" Rating by Ba - GuruFocus
Phreesia Posts Solid Earnings But Shares Drop Anyway - Yahoo Finance
Phreesia, Inc. (NYSE:PHR) Q3 2026 earnings call transcript - MSN
Phreesia, Inc. (NYSE:PHR) Q3 2026 Earnings Call Transcript - Insider Monkey
Citizens reiterates Market Outperform rating on Phreesia stock at $34 By Investing.com - Investing.com Canada
Citizens reiterates Market Outperform rating on Phreesia stock at $34 - Investing.com
Phreesia (PHR) Reports Q3 Earnings: What Key Metrics Have to Say - sharewise.com
Earnings call transcript: Phreesia Q3 2025 earnings beat forecasts, stock rises By Investing.com - Investing.com South Africa
Phreesia Inc (PHR) Q3 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ... - Yahoo Finance UK
Phreesia Reports Strong Q3 2026 Earnings and Positive Outlook - TipRanks
Phreesia (PHR) Reports Strong Q3 with Revenue and EBITDA Growth - GuruFocus
Phreesia Q3 FY2026 slides: revenue up 13%, completes $160M AccessOne acquisition - Investing.com India
Earnings call transcript: Phreesia Q3 2025 earnings beat forecasts, stock rises - Investing.com
Phreesia Q3 2026 Earnings Call Transcript - MarketBeat
Phreesia adjusts fiscal 2026 revenue outlook; introduces FY27 guidance - Seeking Alpha
Phreesia: Fiscal Q3 Earnings Snapshot - New Haven Register
PHREESIA ($PHR) Q3 2026 Earnings Results - Quiver Quantitative
Phreesia (PHR) Projects Revenue Growth and Adjusted EBITDA for F - GuruFocus
PHR Updates Fiscal 2026 Revenue and EBITDA Outlook - GuruFocus
Phreesia Swings to Q3 Earnings, Revenue Increase; Introduces Fiscal 2027 Outlook - marketscreener.com
Phreesia shares rise as company swings to profit in third quarter By Investing.com - Investing.com South Africa
Phreesia Announces Third Quarter Fiscal 2026 Results and Introduces Fiscal 2027 Outlook - TradingView
Phreesia shares rise as company swings to profit in third quarter - Investing.com Canada
(PHR) Phreesia Expects Fiscal 2027 Revenue Range $545M-$559M, vs. FactSet Est of $539.7M - marketscreener.com
(PHR) Phreesia Now Expects Fiscal 2026 Revenue Range $479M-$481M, vs. FactSet Est of $478.6M - marketscreener.com
Earnings Flash (PHR) Phreesia, Inc. Reports Q3 Revenue $120.3M, vs. FactSet Est of $120.0M - marketscreener.com
Phreesia (NYSE: PHR) posts $4.3M Q3 profit, sets 2027 revenue growth outlook - Stock Titan
United StatesCahill Represents Lead Arranger In Phreesia’s $110 Million Credit Facility - Mondaq
Phreesia Stock (PHR) Under Pressure Ahead of Earnings: What to Expect - AskTraders.com
Stock Market Today: Dow Futures Pare Losses, S&P 500, Nasdaq Gain— Carvana, Confluent, Toll Brothers In Focus (UPDATED) - Benzinga
Needham Reiterates "Buy" Rating for Phreesia (PHR) with $35 Targ - GuruFocus
Toll Brothers, Phreesia And 3 Stocks To Watch Heading Into MondayToll Brothers (NYSE:TOL) - Benzinga
Phreesia Inc Stock (PHR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.74%
4.47%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):